{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP04924",
    "Peptide Name": "PRW3 (synthetic AMPs, Arg-rich, UCLL1c, XXA; BBMm)",
    "Source": "amino acid SUBSTITUTION, cathelicidin analog, animal-derived, natural derivatives",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "RFRRLRWWTRKRLKKI",
    "Sequence Length": 16,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Helix",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 10,
    "Boman Index": 5.39,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "38%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is similar (87.5%) toRI-16K: 19%; R: 38%; L=W: 13%.Activity: active against E. coli (MIC 4-8 uM), S. typhimurium 7731 (MIC 8 uM), S. aureus 29213 (MIC 8 uM), S. epidermidis 12228 (MIC 4 uM), S. faecalis 29212 (MIC 8 uM).Antimicrobial robustness: NaCl-insensitive:E. coli (150 mM salt); KCl-insensitive:E. coli (4.5 mM salt); NH4Cl-insensitive:E. coli (6 uM salt); MgCl2-insensitive:E. coli (1 mM salt);  ZnCl2-insensitive:E. coli (8 uM salt); FeCl3-insensitive:E. coli (4 uM salt); Salt-insensitive:S. aureus: NaCl-sensitive:S. aureus (150 mM salt); KCl-insensitive:S. aureus (4.5 mM salt); NH4Cl-insensitive:S. aureus (6 uM salt); MgCl2-insensitive:S. aureus (1 mM salt);  ZnCl2-insensitive:S. aureus (8 uM salt); FeCl3-insensitive:S. aureus (4 uM salt).Structure: random coil in PBS and helical in 50% TFE or 30 mM SDS micelles.In vitro toxicity: human RBC, 5% hemolysis >256 uM, not hemo.lytic.MOA:bacteria:E. coli: permeated bacterial membranes.",
    "Author": "Zhu X, Dong N, Wang Z, Ma Z, Zhang L, Ma Q, Shan A.2014",
    "Reference": "Acta Biomater. 2014 Jan;10(1):244-57. doi: 10.1016/j.actbio.2013.08.043.PubMed",
    "Title": "Design of imperfectly amphipathic alpha-helical antimicrobial peptides with enhanced cell selectivity."
  },
  "3D Structure": []
}